| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
113 |
89 |
$35K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
64 |
62 |
$28K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
38 |
33 |
$20K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
86 |
82 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
165 |
132 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
33 |
33 |
$5K |
| 99233 |
Prolong inpt eval add15 m |
36 |
13 |
$5K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
20 |
19 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
69 |
68 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
45 |
45 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
25 |
20 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
216 |
189 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
14 |
14 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
40 |
38 |
$3K |
| 90461 |
|
42 |
42 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
82 |
74 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
81 |
80 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
26 |
22 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
18 |
18 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
15 |
15 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
16 |
14 |
$1K |
| 70450 |
Computed tomography, head or brain; without contrast material |
12 |
12 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
38 |
35 |
$948.10 |
| 80053 |
Comprehensive metabolic panel |
64 |
51 |
$906.48 |
| 86900 |
|
18 |
15 |
$810.00 |
| 86850 |
|
18 |
15 |
$775.80 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
24 |
20 |
$696.21 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
61 |
57 |
$672.22 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
24 |
21 |
$598.80 |
| 86901 |
|
18 |
15 |
$545.25 |
| 36415 |
Collection of venous blood by venipuncture |
139 |
120 |
$461.16 |
| 99173 |
|
26 |
26 |
$420.42 |
| 82248 |
|
57 |
44 |
$380.17 |
| 85027 |
|
35 |
32 |
$354.02 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$299.40 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
17 |
16 |
$226.10 |
| 83690 |
|
16 |
16 |
$138.62 |
| 85610 |
|
21 |
18 |
$105.94 |
| 81025 |
|
13 |
12 |
$100.55 |
| 85730 |
|
13 |
13 |
$96.16 |
| 82948 |
|
17 |
13 |
$78.40 |
| 81001 |
|
15 |
15 |
$61.71 |
| 81003 |
|
13 |
13 |
$27.72 |